Hyloris Pharmaceuticals SA - ESG Rating & Company Profile powered by AI
The Sustainability score for Hyloris Pharmaceuticals SA indicates the company's transparency towards the UN SDGs. This dashboard includes a Q&A section about Hyloris Pharmaceuticals SA. Other companies in the rating industry group for Hyloris Pharmaceuticals SA are shown below.
Hyloris Pharmaceuticals SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 4.8 and governance score of 3.2.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1234 | Quanterix Corp | 3.4 | Medium |
1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
1253 | Hyloris Pharmaceuticals SA | 3.3 | Medium |
1253 | Calithera Biosciences Inc | 3.3 | Medium |
1253 | Cara Therapeutics Inc | 3.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Hyloris Pharmaceuticals SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA report the average age of the workforce?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose cybersecurity risks?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA offer flexible work?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA conduct supply chain audits?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose water use targets?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Hyloris Pharmaceuticals SA have a product recall in the last two years?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose incidents of discrimination?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Hyloris Pharmaceuticals SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose parental leave metrics?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Hyloris Pharmaceuticals SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose its waste policy?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA report according to TCFD requirements?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose energy use targets?
Sign up for free to unlockDoes Hyloris Pharmaceuticals SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Hyloris Pharmaceuticals SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Hyloris Pharmaceuticals SA
These potential risks are based on the size, segment and geographies of the company.
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was incorporated in 2012 and is headquartered in Liège, Belgium.